[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100399448":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":26,"centralContacts":30,"locations":41,"responsibleParty":59,"collaborators":61,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":70,"eligibilityCriteria":71,"healthyVolunteers":66,"sex":72,"minAge":73,"maxAge":74,"enrollmentInfo":75,"targetDuration":78,"studyType":79,"phases":10,"briefSummary":80,"conditions":81,"keywords":84,"overallStatus":44,"whyStopped":10,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patient with benign gynaecologic disease",null,"Patients consulting for endometriosis, pelvic pain, abnormal uterine bleeding and\u002For infertility, or for a pelvic mass,",[13],"Biological: Biological\u002FVaccine",[15],{"type":16,"name":17,"description":10,"armGroupLabels":18,"otherNames":19},"BIOLOGICAL","Biological\u002FVaccine",[9],[20,21,22,23,24,25],"Peripheral blood,","Vaginal and urinary swab","Endometriosis lesions,endometrial biopsies","Myometer biopsies","Peritoneal fluid","Follicular fluid biopsies",[27],{"name":28,"affiliation":5,"role":29},"Louis Marcellin, MD, PhD","PRINCIPAL_INVESTIGATOR",[31,37],{"name":32,"role":33,"phone":34,"phoneExt":35,"email":36},"Charles Chapron, MD","CONTACT","1 58 41 19 33","+33","charles.chapron@aphp.fr",{"name":38,"role":33,"phone":39,"phoneExt":35,"email":40},"Laurence Lecomte, PhD","1 58 41 34 78","laurence.lecomte@aphp.fr",[42],{"facility":43,"status":44,"city":45,"state":10,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Port Royal, hospital cochin","RECRUITING","Paris","75014","France","FR",{"type":50,"coordinates":51},"Point",[52,53],2.3488,48.85341,{"lat":53,"lon":52},[56],{"name":28,"role":33,"phone":57,"phoneExt":35,"email":58},"1 58415495","louis.marcellin@aphp.fr",{"type":60,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[62],{"name":63,"class":6},"URC-CIC Paris Descartes Necker Cochin","100399448","clinical-and-molecular-study-of-endometriosis-and-adenomyosis-100399448",false,"NCT04481321","Clinical and Molecular Study of Endometriosis and Adenomyosis","ENDOCHAP Monocentric Cohort: Clinical and Molecular Study of Endometriosis and Adenomyosis","ENDOCHAP","Inclusion Criteria:\n\n* Women of age between - 18 and 42 years old.\n* In-service care for one of the pelvic pain and\u002For infertility, or for a pelvic mass.\n* Having a radiological diagnosis made by a referral practitioner and\u002For operated in the department\n\nExclusion Criteria:\n\n* HIV-positive women, HBV and HCV\n* During pregnancy\n* Having a cancer diagnosis\n* Refusing to sign a consent.","FEMALE","18 Years","42 Years",{"count":76,"type":77},5300,"ESTIMATED","10 Years","OBSERVATIONAL","The purpose of this study is to determine whether endometriosis and adenomyosis are progressive diseases, in terms of symptoms (pain, abnormal uterine bleeding and infertility), anatomical lesions size, and recurrences. We also aimed to address molecular questions on immune dialogues between ectopic lesions and the eutopic endometrium, auto-immunity in endometriosis and adenomyosis and the role of the microbiota in their respective pathophysiologies.",[82,83],"Endometriosis","Adenomyosis",[82,83,85,86,87],"pain","infertility","disease progressiveness","2025-11-17",{"date":90,"type":91},"2025-11-20","ACTUAL",{"date":93,"type":91},"2006-05",{"date":95,"type":77},"2040-12",{"name":5,"class":6},1]